Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

David Badesch

Concepts (509)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hypertension, Pulmonary
115
2025
1957
6.510
Why?
Antihypertensive Agents
33
2025
519
2.780
Why?
Epoprostenol
23
2015
132
1.770
Why?
Recombinant Fusion Proteins
9
2025
663
1.380
Why?
Vasodilator Agents
12
2015
326
1.090
Why?
Vascular Resistance
11
2025
365
1.010
Why?
Registries
22
2025
2400
0.970
Why?
Familial Primary Pulmonary Hypertension
17
2024
194
0.950
Why?
Pulmonary Wedge Pressure
9
2024
66
0.900
Why?
Piperazines
8
2014
368
0.860
Why?
Sulfones
7
2012
127
0.850
Why?
Exercise Tolerance
21
2025
289
0.840
Why?
Hemodynamics
30
2024
1114
0.820
Why?
Scleroderma, Systemic
7
2021
124
0.710
Why?
Connective Tissue Diseases
5
2018
85
0.690
Why?
Practice Guidelines as Topic
7
2020
1591
0.680
Why?
Sulfonamides
13
2018
594
0.660
Why?
Exercise Test
12
2025
637
0.660
Why?
Double-Blind Method
26
2025
2070
0.650
Why?
Respiratory System Agents
2
2023
22
0.610
Why?
Natriuretic Peptide, Brain
10
2025
110
0.610
Why?
Phenylpropionates
5
2011
27
0.600
Why?
Pulmonary Artery
14
2023
1116
0.580
Why?
Pyridazines
5
2011
56
0.550
Why?
Adult
79
2025
41087
0.530
Why?
Endothelin Receptor Antagonists
10
2015
60
0.530
Why?
Cardiac Catheterization
13
2024
571
0.530
Why?
Humans
146
2025
146342
0.500
Why?
Middle Aged
81
2025
36619
0.490
Why?
Activins
2
2025
28
0.450
Why?
Treatment Outcome
34
2025
11821
0.440
Why?
Pyrimidines
4
2024
532
0.430
Why?
Lung Transplantation
10
2025
326
0.410
Why?
Disease Management
6
2016
651
0.410
Why?
Male
93
2025
73396
0.390
Why?
Female
90
2025
79499
0.380
Why?
Aged
44
2025
26432
0.370
Why?
Risk Assessment
14
2024
3712
0.360
Why?
Consensus
1
2014
467
0.360
Why?
Thrombosis
1
2016
398
0.360
Why?
Anticoagulants
3
2016
746
0.340
Why?
Anemia, Sickle Cell
5
2014
324
0.340
Why?
Pyrazoles
3
2024
517
0.320
Why?
Prognosis
16
2021
4351
0.320
Why?
Thinness
1
2011
100
0.310
Why?
Prostaglandins
3
2007
94
0.310
Why?
Survival Rate
15
2022
2092
0.300
Why?
Blood Pressure
8
2014
1765
0.290
Why?
Oxygen Consumption
1
2012
721
0.290
Why?
Hypertension, Portal
4
2011
66
0.280
Why?
Activities of Daily Living
3
2016
442
0.280
Why?
Sildenafil Citrate
8
2014
60
0.280
Why?
Follow-Up Studies
18
2025
5439
0.270
Why?
Coagulants
1
2008
20
0.270
Why?
Factor VIIa
1
2008
43
0.270
Why?
Lung Neoplasms
1
2021
2675
0.260
Why?
Hospitalization
9
2025
2475
0.260
Why?
Purines
8
2014
188
0.250
Why?
Depressive Disorder
1
2010
361
0.250
Why?
Surveys and Questionnaires
2
2018
6073
0.250
Why?
Drug Therapy, Combination
8
2025
1036
0.250
Why?
Quality of Life
12
2025
3200
0.250
Why?
Evidence-Based Medicine
4
2019
731
0.250
Why?
Mixed Connective Tissue Disease
2
2010
10
0.250
Why?
Health Status
2
2016
827
0.230
Why?
Bone Morphogenetic Protein Receptors, Type II
2
2025
51
0.230
Why?
Pulmonary Medicine
3
2019
78
0.220
Why?
Prospective Studies
16
2021
8123
0.220
Why?
Phosphodiesterase 5 Inhibitors
3
2014
41
0.220
Why?
Pulmonary Disease, Chronic Obstructive
1
2012
928
0.210
Why?
Hemorrhage
2
2008
825
0.210
Why?
Dose-Response Relationship, Drug
11
2021
2022
0.200
Why?
Castleman Disease
1
2003
16
0.200
Why?
Walk Test
4
2025
82
0.190
Why?
Herpesvirus 8, Human
1
2003
67
0.190
Why?
DEAE-Dextran
1
2023
1
0.190
Why?
Referral and Consultation
2
2025
881
0.190
Why?
United States
21
2025
16136
0.190
Why?
Muscle, Smooth, Vascular
6
1994
449
0.180
Why?
Phosphodiesterase Inhibitors
4
2009
73
0.180
Why?
Peptide Fragments
5
2025
693
0.180
Why?
Herpesviridae Infections
1
2003
147
0.180
Why?
Adolescent
22
2021
22557
0.180
Why?
Disease Progression
6
2025
2867
0.180
Why?
Body Mass Index
1
2011
2458
0.180
Why?
Ventricular Function, Right
5
2009
300
0.180
Why?
Biomarkers
6
2021
4340
0.170
Why?
Insulin-Like Growth Factor I
4
1994
320
0.170
Why?
Lung
7
2019
4122
0.160
Why?
Medication Adherence
1
2025
535
0.160
Why?
Fluid Shifts
1
2020
2
0.160
Why?
Adenocarcinoma, Mucinous
1
2021
76
0.160
Why?
Severity of Illness Index
10
2024
2921
0.160
Why?
Rituximab
1
2021
208
0.160
Why?
Kaplan-Meier Estimate
5
2025
970
0.160
Why?
Heart
2
2023
626
0.150
Why?
Methamphetamine
1
2021
75
0.150
Why?
Infusions, Intravenous
7
2009
432
0.150
Why?
Vasculitis
2
1998
69
0.150
Why?
Exercise Therapy
1
2025
488
0.150
Why?
Somatomedins
2
1990
28
0.150
Why?
Echocardiography
4
2020
645
0.150
Why?
Walking
8
2014
546
0.150
Why?
Sodium Chloride
1
2020
138
0.150
Why?
Thorax
1
2019
51
0.140
Why?
Diagnostic Techniques, Respiratory System
1
2019
5
0.140
Why?
Endothelin A Receptor Antagonists
2
2011
24
0.140
Why?
HLA-DP alpha-Chains
1
2018
4
0.140
Why?
Immunologic Factors
1
2021
244
0.140
Why?
Isoxazoles
3
2008
57
0.140
Why?
SOXF Transcription Factors
1
2018
16
0.140
Why?
Thiophenes
3
2008
117
0.140
Why?
Transforming Growth Factor beta
1
2021
467
0.140
Why?
HLA-DP beta-Chains
1
2018
88
0.140
Why?
Administration, Oral
9
2015
872
0.130
Why?
Time Factors
14
2018
7109
0.130
Why?
Young Adult
10
2021
14330
0.130
Why?
Algorithms
5
2019
1849
0.130
Why?
Liver Diseases
3
2011
304
0.130
Why?
Blood Coagulation
2
2016
267
0.130
Why?
Obesity
1
2011
3131
0.130
Why?
Psychometrics
2
2018
712
0.120
Why?
Comorbidity
5
2019
1665
0.120
Why?
Proportional Hazards Models
6
2022
1331
0.120
Why?
Diagnostic Imaging
1
2019
340
0.120
Why?
Oxygen Inhalation Therapy
1
2018
190
0.110
Why?
B-Lymphocytes
1
2021
887
0.110
Why?
Randomized Controlled Trials as Topic
5
2024
1763
0.110
Why?
Pyridines
2
2015
610
0.110
Why?
Iloprost
2
2006
45
0.110
Why?
Drug Monitoring
1
2019
399
0.110
Why?
Calcium Channel Blockers
2
2024
165
0.110
Why?
Pulmonary Edema
1
1995
105
0.110
Why?
Tetrazoles
1
2015
50
0.110
Why?
Cohort Studies
7
2020
6077
0.110
Why?
Graft Rejection
1
1998
516
0.100
Why?
Hemolysis
2
2014
242
0.100
Why?
Survival Analysis
8
2018
1378
0.100
Why?
Models, Theoretical
2
2015
561
0.100
Why?
Case-Control Studies
5
2018
3647
0.100
Why?
Antibodies, Antinuclear
1
1993
60
0.100
Why?
Pilot Projects
4
2010
1888
0.100
Why?
Acute Disease
3
2008
1038
0.100
Why?
Protein Kinase C
2
1994
250
0.100
Why?
Hypothyroidism
1
1993
68
0.090
Why?
Societies, Medical
2
2015
907
0.090
Why?
Echocardiography, Doppler
2
2014
117
0.090
Why?
Pancreatic Neoplasms
1
2021
944
0.090
Why?
Colorado
3
2022
4595
0.090
Why?
Respiratory Function Tests
5
2018
543
0.090
Why?
Exercise
4
2024
2213
0.090
Why?
Delphi Technique
1
2014
350
0.090
Why?
Endpoint Determination
2
2010
84
0.090
Why?
Incidence
5
2015
2936
0.090
Why?
Injections, Subcutaneous
2
2023
170
0.090
Why?
Patient Reported Outcome Measures
1
2016
516
0.090
Why?
Pulmonary Circulation
3
2018
431
0.090
Why?
Survival
1
2011
38
0.080
Why?
Diagnosis, Differential
3
2020
1503
0.080
Why?
Peptidyl-Dipeptidase A
3
2003
57
0.080
Why?
Risk Factors
9
2018
10921
0.080
Why?
Pain
2
2011
790
0.080
Why?
United Kingdom
3
2021
377
0.080
Why?
Extracorporeal Membrane Oxygenation
1
1995
370
0.080
Why?
Prevalence
4
2010
2861
0.080
Why?
Long-Term Care
1
2011
118
0.080
Why?
Reference Values
2
2009
796
0.080
Why?
Respiration, Artificial
1
1995
711
0.080
Why?
Michigan
1
2010
203
0.080
Why?
Animals, Newborn
5
1994
888
0.070
Why?
Endothelin-1
2
2002
177
0.070
Why?
Retrospective Studies
8
2025
17438
0.070
Why?
Pulmonary Alveoli
2
2005
385
0.070
Why?
Guideline Adherence
2
2018
594
0.070
Why?
Aldosterone
1
2009
42
0.070
Why?
Dinoprostone
1
1989
179
0.070
Why?
Elastin
1
1989
78
0.070
Why?
Vasopressins
1
2009
60
0.070
Why?
Pulmonary Eosinophilia
1
1989
28
0.070
Why?
Transaminases
1
2008
22
0.070
Why?
Serotonin Plasma Membrane Transport Proteins
1
2009
61
0.070
Why?
Vasoconstrictor Agents
1
2009
148
0.070
Why?
Renal Insufficiency
1
2010
173
0.070
Why?
Ventricular Dysfunction, Left
1
2011
391
0.070
Why?
Maximum Tolerated Dose
2
2025
217
0.070
Why?
Alveolitis, Extrinsic Allergic
1
1989
96
0.070
Why?
Aged, 80 and over
8
2021
8391
0.070
Why?
Hospitals, University
1
2008
178
0.070
Why?
Multivariate Analysis
4
2015
1543
0.070
Why?
Lung Diseases
2
2010
787
0.070
Why?
Heart Failure
2
2020
2329
0.060
Why?
Platelet Aggregation Inhibitors
3
2004
499
0.060
Why?
Ventricular Dysfunction, Right
3
2009
248
0.060
Why?
Airway Obstruction
1
2009
152
0.060
Why?
Lupus Erythematosus, Systemic
3
2010
241
0.060
Why?
Genetic Predisposition to Disease
3
2018
2488
0.060
Why?
Drug Utilization
1
2008
171
0.060
Why?
Endothelins
1
2007
61
0.060
Why?
Drug Costs
1
2008
116
0.060
Why?
Hypophosphatemia
1
2006
16
0.060
Why?
Hypokalemia
1
2006
23
0.060
Why?
Appetite Depressants
1
2006
19
0.060
Why?
Clinical Trials as Topic
2
2009
1064
0.060
Why?
Autoimmune Diseases
2
2005
467
0.060
Why?
Phosphorus
1
2006
89
0.060
Why?
Educational Measurement
1
1989
331
0.060
Why?
Potassium
1
2006
151
0.060
Why?
Ventricular Function
1
2006
53
0.060
Why?
3',5'-Cyclic-GMP Phosphodiesterases
1
2005
17
0.060
Why?
Cattle
5
1994
940
0.060
Why?
Telangiectasis
1
2025
7
0.060
Why?
Epistaxis
1
2025
16
0.060
Why?
Medical Informatics
1
2006
102
0.060
Why?
CREST Syndrome
2
2002
6
0.060
Why?
Pleural Diseases
1
2005
23
0.060
Why?
Analysis of Variance
3
2009
1298
0.060
Why?
Probability
3
2015
309
0.060
Why?
Forecasting
3
2021
388
0.050
Why?
Immunohistochemistry
3
2005
1712
0.050
Why?
Child
6
2011
22693
0.050
Why?
Recombinant Proteins
1
2008
1361
0.050
Why?
Predictive Value of Tests
3
2016
2113
0.050
Why?
Clinical Trials, Phase III as Topic
1
2024
116
0.050
Why?
Arthritis, Rheumatoid
3
2010
1185
0.050
Why?
Carbon Monoxide
2
2018
82
0.050
Why?
Heterozygote
1
2025
311
0.050
Why?
Physicians, Family
1
2005
179
0.050
Why?
Age Distribution
3
2010
399
0.050
Why?
Sex Distribution
3
2010
382
0.050
Why?
Physician's Role
1
2005
225
0.050
Why?
Terminology as Topic
1
2005
253
0.050
Why?
Neoplasm Metastasis
1
2005
693
0.050
Why?
Polymyositis
1
2002
13
0.050
Why?
Statistics, Nonparametric
2
2003
426
0.050
Why?
Scleroderma, Localized
1
2002
11
0.050
Why?
Dermatomyositis
1
2002
24
0.050
Why?
Serotonin Antagonists
1
2002
33
0.050
Why?
Thromboxane-A Synthase
1
2002
3
0.050
Why?
Heart Defects, Congenital
2
2009
923
0.050
Why?
Liver Function Tests
3
2011
103
0.050
Why?
Polymerase Chain Reaction
2
2003
1031
0.040
Why?
Enzyme Inhibitors
2
2004
823
0.040
Why?
Hypoxia
3
2018
1211
0.040
Why?
Drug Administration Schedule
4
2008
790
0.040
Why?
Cardiac Surgical Procedures
1
2008
611
0.040
Why?
Mutation
2
2025
4093
0.040
Why?
Signal Transduction
4
2025
5246
0.040
Why?
Animals
11
2013
38107
0.040
Why?
Biomarkers, Pharmacological
1
2021
26
0.040
Why?
Cholangiopancreatography, Magnetic Resonance
1
2021
24
0.040
Why?
Tricuspid Valve Insufficiency
2
2011
23
0.040
Why?
Cardiovascular Agents
1
2023
165
0.040
Why?
Least-Squares Analysis
1
2021
73
0.040
Why?
Injections, Intravenous
2
2013
197
0.040
Why?
Adjuvants, Immunologic
1
2002
245
0.040
Why?
Clinical Competence
1
1989
1272
0.040
Why?
Polymorphism, Single Nucleotide
3
2018
2240
0.040
Why?
Multicenter Studies as Topic
2
2006
417
0.040
Why?
Tropoelastin
2
1991
11
0.040
Why?
Reproductive History
1
2020
12
0.040
Why?
Cells, Cultured
5
1994
4118
0.040
Why?
Risk
2
2015
920
0.040
Why?
Self Report
1
2025
870
0.040
Why?
Lymph Nodes
1
2003
511
0.040
Why?
Europe
2
2012
421
0.040
Why?
Infusion Pumps
1
2000
33
0.040
Why?
Jaw
1
2000
27
0.040
Why?
Cardiac Output
1
2020
176
0.040
Why?
Radiography
2
1995
861
0.040
Why?
Genotype
4
2009
1879
0.040
Why?
Delivery of Health Care
1
2006
947
0.040
Why?
Transplantation, Homologous
2
1998
416
0.040
Why?
Autoimmunity
1
2005
925
0.040
Why?
Placebos
2
2011
192
0.040
Why?
Reproducibility of Results
2
2019
3416
0.040
Why?
Symptom Assessment
1
2020
138
0.040
Why?
Spinal Diseases
1
1999
50
0.040
Why?
Intramolecular Oxidoreductases
1
1999
64
0.040
Why?
Gonadal Steroid Hormones
1
2020
143
0.040
Why?
Thrombocytopenia
1
2021
206
0.040
Why?
Uric Acid
1
2000
167
0.030
Why?
Internship and Residency
1
1989
1281
0.030
Why?
Lung Diseases, Interstitial
1
2005
677
0.030
Why?
Genotyping Techniques
1
2018
74
0.030
Why?
Immunosuppressive Agents
3
1998
829
0.030
Why?
Cytochrome P-450 Enzyme System
1
1999
163
0.030
Why?
Methicillin Resistance
1
1998
17
0.030
Why?
Plasmapheresis
1
1998
24
0.030
Why?
Cell Division
4
1994
736
0.030
Why?
Pulmonary Diffusing Capacity
1
2018
78
0.030
Why?
Hemoptysis
1
1998
34
0.030
Why?
Bronchiolitis Obliterans
1
1998
59
0.030
Why?
Models, Statistical
1
2022
669
0.030
Why?
Gastrointestinal Diseases
1
2000
220
0.030
Why?
Cervical Vertebrae
1
1999
170
0.030
Why?
alpha 1-Antitrypsin Deficiency
1
1998
61
0.030
Why?
Disease-Free Survival
2
2010
778
0.030
Why?
Fatal Outcome
1
1998
302
0.030
Why?
Biomedical Technology
1
2017
49
0.030
Why?
Capillaries
1
1998
123
0.030
Why?
Child, Preschool
2
2011
11913
0.030
Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
1997
43
0.030
Why?
Health Status Indicators
2
2009
167
0.030
Why?
Myosin Heavy Chains
1
1997
177
0.030
Why?
Faculty, Medical
2
1990
309
0.030
Why?
Colonic Diseases
1
1996
39
0.030
Why?
Mycoplasma
1
1996
5
0.030
Why?
Intestinal Perforation
1
1996
46
0.030
Why?
Mycoplasma Infections
1
1996
17
0.030
Why?
Desensitization, Immunologic
1
1997
91
0.030
Why?
Mass Screening
2
2018
1307
0.030
Why?
Translating
1
2016
46
0.030
Why?
Cardiomyopathy, Dilated
1
1999
357
0.030
Why?
Blood Coagulation Factors
1
1996
71
0.030
Why?
Drug Hypersensitivity
1
1997
93
0.030
Why?
Myocardium
2
1998
948
0.030
Why?
Comparative Effectiveness Research
1
2016
171
0.030
Why?
Endothelium, Vascular
2
1994
952
0.030
Why?
Pulmonary Emphysema
1
1998
276
0.030
Why?
Dyspnea
2
2008
251
0.030
Why?
Fibrinolysis
1
1996
162
0.030
Why?
Lactobacillus
1
1994
28
0.030
Why?
Calibration
1
2015
154
0.030
Why?
Recurrence
1
1998
1133
0.030
Why?
Tetradecanoylphorbol Acetate
2
1994
128
0.030
Why?
Immunization, Passive
1
1994
90
0.030
Why?
Drug Approval
1
2015
94
0.030
Why?
Longitudinal Studies
2
2014
3017
0.030
Why?
Antisickling Agents
1
2014
8
0.030
Why?
Ferritins
1
2014
69
0.030
Why?
South Africa
1
2015
262
0.030
Why?
Hydroxyurea
1
2014
36
0.030
Why?
Immunoglobulins
1
1994
162
0.030
Why?
United States Food and Drug Administration
1
2015
208
0.030
Why?
Social Behavior
1
2016
279
0.020
Why?
Gram-Positive Bacterial Infections
1
1994
72
0.020
Why?
Thyroiditis
1
1993
4
0.020
Why?
Raynaud Disease
1
1993
3
0.020
Why?
Staphylococcal Infections
1
1998
397
0.020
Why?
Research
2
2009
421
0.020
Why?
Genetic Variation
1
2018
996
0.020
Why?
Cross-Sectional Studies
3
2016
5899
0.020
Why?
Cytomegalovirus
1
1994
172
0.020
Why?
Pneumonia, Bacterial
1
1994
114
0.020
Why?
Administration, Intravenous
1
2014
172
0.020
Why?
Immunoenzyme Techniques
2
1994
197
0.020
Why?
Focus Groups
1
2016
588
0.020
Why?
Enzyme Activation
2
1994
759
0.020
Why?
Emergency Service, Hospital
1
2025
2363
0.020
Why?
Erythrocyte Indices
1
2012
33
0.020
Why?
Blood Flow Velocity
1
2014
419
0.020
Why?
Down Syndrome
1
1999
529
0.020
Why?
Cytomegalovirus Infections
1
1994
206
0.020
Why?
Creatinine
1
2014
511
0.020
Why?
Pulmonary Embolism
1
2015
246
0.020
Why?
Embolism, Air
1
1992
14
0.020
Why?
Erythrocyte Transfusion
1
2014
226
0.020
Why?
Cell-Derived Microparticles
1
2012
73
0.020
Why?
Genome-Wide Association Study
1
2018
1537
0.020
Why?
Chronic Disease
2
2015
1827
0.020
Why?
Cardiomegaly
2
2006
175
0.020
Why?
Homozygote
1
2011
197
0.020
Why?
Preoperative Care
2
2009
396
0.020
Why?
Biomedical Research
1
2017
729
0.020
Why?
Emotions
1
2016
559
0.020
Why?
Thromboxane B2
1
1989
23
0.020
Why?
Calcimycin
1
1989
36
0.020
Why?
Mortality
1
2012
375
0.020
Why?
Nitric Oxide
1
1994
883
0.020
Why?
Phenotype
3
2010
3206
0.020
Why?
Drug Synergism
1
1990
354
0.020
Why?
Mental Health
1
2016
779
0.020
Why?
Cost-Benefit Analysis
1
2012
640
0.020
Why?
Decision Support Techniques
1
2014
478
0.020
Why?
Angiopoietin-1
1
2009
12
0.020
Why?
Cyclic Nucleotide Phosphodiesterases, Type 5
1
2009
23
0.020
Why?
Health Policy
1
2012
399
0.020
Why?
Receptors, Retinoic Acid
1
2009
44
0.020
Why?
Health Care Costs
1
2012
423
0.020
Why?
Aromatase
1
2009
37
0.020
Why?
Spironolactone
1
2009
40
0.020
Why?
Nucleic Acid Hybridization
1
1989
175
0.020
Why?
Fellowships and Scholarships
2
1990
355
0.020
Why?
Dyspepsia
1
2008
11
0.020
Why?
In Vitro Techniques
1
1990
1041
0.020
Why?
California
1
2010
475
0.020
Why?
Hepatitis, Autoimmune
1
2008
11
0.020
Why?
Pulmonary Veins
1
1989
110
0.020
Why?
Mineralocorticoid Receptor Antagonists
1
2009
69
0.020
Why?
Qualitative Research
1
2016
1734
0.020
Why?
Vital Capacity
1
2009
293
0.020
Why?
Confidence Intervals
1
2009
329
0.020
Why?
Vibrio Infections
1
1987
2
0.020
Why?
Echocardiography, Transesophageal
1
2009
132
0.020
Why?
Down-Regulation
1
1990
614
0.020
Why?
Cystic Fibrosis
1
1998
1164
0.020
Why?
Forced Expiratory Volume
1
2009
451
0.020
Why?
Cognition
1
2016
1292
0.020
Why?
Calcium-Binding Proteins
1
2009
221
0.020
Why?
Headache
1
2008
150
0.020
Why?
Estrogen Receptor alpha
1
2009
154
0.020
Why?
American Heart Association
1
2009
364
0.020
Why?
Endocarditis, Bacterial
1
1987
46
0.020
Why?
Aminorex
1
2006
2
0.020
Why?
Heart Rate
1
2010
846
0.010
Why?
RNA, Messenger
2
1997
2791
0.010
Why?
Protein Biosynthesis
1
1989
449
0.010
Why?
Odds Ratio
1
2009
1077
0.010
Why?
Alleles
1
2009
907
0.010
Why?
Hypoventilation
1
1985
17
0.010
Why?
Hepatitis C
1
2008
251
0.010
Why?
Statistics as Topic
1
2006
279
0.010
Why?
Biopsy, Needle
1
2005
183
0.010
Why?
Estradiol
1
2009
517
0.010
Why?
Gene Expression Regulation
2
1997
2599
0.010
Why?
Magnesium
1
1985
155
0.010
Why?
Magnetic Resonance Imaging
3
2006
3926
0.010
Why?
Pancreatic Elastase
1
2004
54
0.010
Why?
Hypotension
1
1985
125
0.010
Why?
Drug Prescriptions
1
2006
314
0.010
Why?
Fibroblasts
1
1989
1034
0.010
Why?
Sensitivity and Specificity
1
2009
1998
0.010
Why?
DNA
1
1990
1421
0.010
Why?
Logistic Models
1
2009
2126
0.010
Why?
Potassium Channels
1
2004
149
0.010
Why?
Tablets
1
2003
41
0.010
Why?
Aging
1
1994
1996
0.010
Why?
Critical Care
1
1989
706
0.010
Why?
Research Design
1
2009
1143
0.010
Why?
Arginine
1
2004
264
0.010
Why?
Angiotensin II
1
2003
102
0.010
Why?
Sex Factors
1
2008
2107
0.010
Why?
Liver Transplantation
1
2009
751
0.010
Why?
Rats
2
2004
5586
0.010
Why?
Attitude of Health Personnel
1
2010
1219
0.010
Why?
Sepsis
1
1987
669
0.010
Why?
Heart Ventricles
1
2006
762
0.010
Why?
Practice Patterns, Physicians'
1
2010
1408
0.010
Why?
Colorimetry
1
2000
12
0.010
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2004
449
0.010
Why?
Spinal Osteophytosis
1
1999
3
0.010
Why?
Spinal Cord Compression
1
1999
24
0.010
Why?
Spinal Stenosis
1
1999
31
0.010
Why?
Ovarian Neoplasms
1
2005
604
0.010
Why?
Veins
1
1999
68
0.010
Why?
Heart Atria
1
2000
139
0.010
Why?
In Situ Hybridization
1
1999
317
0.010
Why?
Calcium-Transporting ATPases
1
1997
33
0.010
Why?
Atrial Natriuretic Factor
1
1997
54
0.010
Why?
Arteries
1
1999
261
0.010
Why?
Heart-Lung Transplantation
1
1997
12
0.010
Why?
Receptors, Adrenergic, beta
1
1997
58
0.010
Why?
Tissue Distribution
1
1997
334
0.010
Why?
Liver Cirrhosis
1
1999
278
0.010
Why?
Models, Biological
1
2004
1761
0.010
Why?
Blotting, Western
1
1999
1177
0.010
Why?
Spinal Cord
1
1999
378
0.010
Why?
Systole
1
1997
179
0.010
Why?
Diverticulitis, Colonic
1
1996
11
0.010
Why?
von Willebrand Factor
1
1996
84
0.010
Why?
Respiration
1
1996
208
0.010
Why?
Proteins
2
1992
1022
0.010
Why?
Physical Fitness
1
1997
209
0.010
Why?
Ventricular Function, Left
1
1999
541
0.010
Why?
Cilazapril
1
1995
1
0.010
Why?
Electrophoresis, Agar Gel
1
1995
26
0.010
Why?
Thymidine
1
1994
57
0.010
Why?
Ganciclovir
1
1994
51
0.010
Why?
Subcellular Fractions
1
1994
73
0.010
Why?
Opportunistic Infections
1
1994
47
0.010
Why?
Lung Diseases, Obstructive
1
1994
43
0.010
Why?
Image Processing, Computer-Assisted
1
1999
778
0.010
Why?
Acyclovir
1
1994
97
0.010
Why?
Blood
1
1994
107
0.010
Why?
Tissue Donors
1
1997
425
0.010
Why?
Vimentin
1
1994
47
0.010
Why?
Immunoglobulins, Intravenous
1
1994
134
0.010
Why?
Viremia
1
1994
158
0.010
Why?
Gene Expression
1
1998
1463
0.010
Why?
Liver
1
2002
1864
0.010
Why?
Factor VIII
1
1994
107
0.010
Why?
Administration, Inhalation
1
1994
567
0.010
Why?
Immunocompromised Host
1
1994
201
0.010
Why?
Sputum
1
1994
302
0.010
Why?
Neovascularization, Pathologic
1
1994
287
0.010
Why?
Lymph
1
1992
31
0.010
Why?
Blotting, Northern
1
1991
197
0.010
Why?
Flow Cytometry
1
1994
1163
0.000
Why?
Extracellular Matrix Proteins
1
1991
156
0.000
Why?
Antibodies, Viral
1
1994
689
0.000
Why?
Financing, Government
1
1990
53
0.000
Why?
Research Support as Topic
1
1990
83
0.000
Why?
Career Mobility
1
1990
68
0.000
Why?
National Institutes of Health (U.S.)
1
1990
147
0.000
Why?
Pneumonia, Viral
1
1994
387
0.000
Why?
Rats, Sprague-Dawley
1
1995
2537
0.000
Why?
Sheep
1
1992
870
0.000
Why?
Tomography, X-Ray Computed
1
1999
2786
0.000
Why?
Vibrio
1
1987
4
0.000
Why?
Hepatitis, Alcoholic
1
1987
18
0.000
Why?
Citrates
1
1985
41
0.000
Why?
Protein Binding
1
1992
2244
0.000
Why?
Kidney Function Tests
1
1985
156
0.000
Why?
RNA
1
1991
926
0.000
Why?
Postoperative Complications
1
1997
3034
0.000
Why?
Disease Models, Animal
1
1995
4580
0.000
Why?
Anti-Bacterial Agents
1
1994
1942
0.000
Why?
HIV Infections
1
1999
3215
0.000
Why?
Infant
1
1994
10114
0.000
Why?
Badesch's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)